GF-TADs for Africa

Inaugural CBPP Standing Group of Experts (SGE) meeting endorses a 6-point work plan

Header

Pastoralist with cattle - Mali Picture (c) N. Denormandie (pace) 2004

Pastoralist with cattle – Mali. Picture (c) N. Denormandie (pace) 2004

 

This inaugural meeting was organised as a result of the adoption in June 2022 of the terms of reference for the Africa-region Standing Group of Experts (SGE) for Contagious bovine pleuropneumonia (CBPP) by the 11th  Regional Steering Committee (RSC-11) of the GF-TADs for Africa. The SGE-CBPP for Africa aims to promote regular exchange of information and best practices among concerned national veterinary authorities, international, regional and national experts, and the private sector. The disease was identified as one of the 5 priority diseases under the GF-TADs Regional Strategy 2021 – 2025, adopted in October 2021.

As per the terms of reference, the SGE-CBPP for Africa would start with a core group of 4 founding Members Countries drawn from Central (Chad), Eastern (Somalia), Southern (Zambia) and Western Africa (Nigeria), with the aim to progressively extend to more countries.

The launch meeting was attended by all 4 founding member countries (mentioned above) that have extensive experience in controlling CBPP and responded to a public call for expression of interest (December 2021 – January 2022) to join the SGE as Member country. The call also invited expressions of interest from institutions and individuals.

Also present at the launch were the African Union Interafrican Bureau for Animal Resources, the Regional  Animal Health Centre for the Economic Community of West African States (RAHC for ECOWAS), the Secretariat of the Common Market for Eastern and Southern Africa (COMESA), FAO and WOAH Regional Representations, WOAH and FAO Reference Laboratories as well as selected national / regional laboratories : Pan African Veterinary Vaccine Centre of the African Union (AU—PANVAC); the National Veterinary Research Institute (NVRI), Vom, Nigeria; the Animal Health Institute (AHI), Sebeta – Ethiopia; the Botswana National Veterinary Laboratory (BNVL) Sebele, Gaborone – Botswana; and the Laboratoire Central Vétérinaire (LCV) Sotuba, Bamako – Mali.

Overall the meeting was attended by a cumulative total of 45 participants over the 6 daily meetings (up to 33 participants per day) between 6 – 15 June 2023. Forty per-cent (40%) of participants was French-speaking, while 23% were women.

Training on: Recognition of CBPP lesions. Central Veterinary Research Institute Lusaka, Zambia, 20-25 September 2015. Organised by CVRI and WOAH RL Teramo sponsored by GALVmed, involving Namibia, Angola, Botswana, Zambia. Picture (c) IZS Teramo (2015)

Training on: Recognition of CBPP lesions. Central Veterinary Research Institute Lusaka, Zambia, 20-25 September 2015. Organised by CVRI and WOAH RL Teramo sponsored by GALVmed, involving Namibia, Angola, Botswana, Zambia. Picture (c) IZS Teramo (2015)

 

Based on the expected outcomes of this meeting and follow-up activities, being:

  1. The SGE – CBPP for Africa is established and launched to guide on technical aspects of CBPP control at the national and (sub)regional levels;
  2. The SGE – CBPP for Africa Terms of Reference are shared ;
  3. The topics to be covered by SGE – CBPP for Africa are identified and validated;
  4. The support of FAO and WOAH to the Member Countries is strengthened.

…the following agenda was prepared, fostering as much exchange of information and discussion between participants as possible (download the agenda below).

Download the agenda and download the report

Agenda online (EN)
Agenda online (EN)

PDF - 203.62KB

Final version of the report in English
Final version of the report in English

PDF - 1.96MB

Download the presentations here (1 - 2)

01. Kamata - FAO
01. Kamata - FAO

PDF - 924.35KB

02. Bastiaensen - WOAH - 1
02. Bastiaensen - WOAH - 1

PDF - 879.19KB

02. Bastiaensen - WOAH - 2
02. Bastiaensen - WOAH - 2

PDF - 1.16MB

Download the presentations here (3 - 4)

03. Awada - WOAH
03. Awada - WOAH

PDF - 3.87MB

04. Sidibe - IBAR
04. Sidibe - IBAR

PDF - 331.69KB

Download the presentations here (5 - 6) Country presentations

05. Tchad - Chad
05. Tchad - Chad

PDF - 368.79KB

06. Nigeria
06. Nigeria

PDF - 506.88KB

Download the presentations here (7 - 8) Country presentations

07. Somalia - Somalie
07. Somalia - Somalie

PDF - 207.51KB

08. Zambia - Zambie
08. Zambia - Zambie

PDF - 1.52MB

Download the presentations here (9 - 10) Code standards and official freedom status

09. Tounkara - WOAH
09. Tounkara - WOAH

PDF - 1.24MB

10. Park - WOAH
10. Park - WOAH

PDF - 2.84MB

Download the presentations here (11 - 13) Laboratory diagnosis

11. Marobela - BNVL
11. Marobela - BNVL

PDF - 6.10MB

12. Kingsley - NVRI Vom
12. Kingsley - NVRI Vom

PDF - 3.14MB

13. Tesfaye - AHI Sebeta
13. Tesfaye - AHI Sebeta

PDF - 1.16MB

Download the presentations here (14 - 17) Laboratory diagnosis

14. Sery - LCV Bamako
14. Sery - LCV Bamako

PDF - 332.61KB

15. Tesfaye - AHI Sebeta
15. Tesfaye - AHI Sebeta

PDF - 1.52MB

17. Scacchia - IZS ERFAN
17. Scacchia - IZS ERFAN

PDF - 4.99MB

Download the presentations here (18 - 20) Prophylaxis and treatment

18. Bodjo - PANVAC
18. Bodjo - PANVAC

PDF - 1.25MB

19. Wesonga - KALRO
19. Wesonga - KALRO

PDF - 300.66KB

Download the presentations here (21 - 24) Prophylaxis and treatment

22. Niang - FAO
22. Niang - FAO

PDF - 975.65KB

23. Singano - TVLA Arusha
23. Singano - TVLA Arusha

PDF - 2.29MB

24. Scacchia - IZS ERFAN
24. Scacchia - IZS ERFAN

PDF - 8.99MB

Download the presentations here (25 - 28) Policy issues

26. Muuka - Zambia
26. Muuka - Zambia

PDF - 254.08KB

27. Tizzani - WOAH
27. Tizzani - WOAH

PDF - 2.62MB

28. Gelaw - PANVAC
28. Gelaw - PANVAC

PDF - 1.75MB

Download the presentations here (29 - 31) Policy issues

29. Mamo - COMESA
29. Mamo - COMESA

PDF - 638.50KB

31. Kamata - FAO
31. Kamata - FAO

PDF - 1.44MB

Resulting from the various presentations made during the 6 sessions, the last part of session 6 (on 15 June) was dedicated to the preparation of the following considerations, and the following technical items or topics identified, to guide the work of the SGE over the next 12 – 24 months, depending on the frequency of meetings —

Considering:

  1. The absence of a global framework for the control and eradication of CBPP;
  2. The absence of a continental framework for the control and eradication of CBPP from Africa;
  3. The absence of a global or continental CBPP research alliance;
  4. The absence of a pipeline of new vaccines (alone or in combo) in the foreseeable future;
  5. The general unsatisfactory features of the existing T1-based live attenuated vaccines (including issues surrounding vial size, diluents, storage);
  6. The widespread use of (over-the counter) antibiotics in the self-medication of the disease by farmers;
  7. The general requirements (for these and other vaccines, targeting other TADs) of cold chain management;
  8. The perceived threats to hitherto disease-free countries in North Africa, e.g. Algeria, Egypt, Libya, Morocco and Tunisia;

…the following technical items or topics were identified (in order of priority and logic/sequence of implementation) with comments (where appropriate) on possible secondary items or topics, some of which apply to several identified topics:

Topic

Definition

Scope

1.     Strategy

Development and validation of strategic plans at various levels of governance (national, clusters of neighbouring countries, sub-regions, the continent and/or the international community, for higher prioritisation of the disease (technically and financially).
  • Global strategy (disease limited to Africa, but seeking global declaration of freedom);
  • Continental strategy (custodian: African Union);
  • Sub-regional strategies (custodian: regional economic communities);
  • National strategies (clustering with neighbouring countries, shared borders).

2.     Surveillance

Enhanced surveillance leading to improved disease intelligence for better and more reliable reporting of the disease.
  • Renewed efforts to focus on the cheap and effective abattoir surveillance as the tool of choice (including in free countries in Southern and North Africa);
  • Developing standardised reporting templates and harmonised procedures for abattoir surveillance;
  • Developing guidelines and delivery of training on abattoir surveillance (including in free countries in Southern and North Africa);
  • Promoting novel tools for events-based surveillance, e-reporting and tele-health or tele-diagnosis;
  • Upgrading infrastructures to support abattoir surveillance;
  • Promoting networking and information sharing at (sub)regional level(s), including in free countries in Southern and North Africa and leveraging existing platforms where possible;
  • Promoting the transparent reporting of cases and vaccination numbers (and fighting reporting aversion);
  • Promoting countries to engage in official pathways (dossier preparation, submission): status recognition (in particular for disease-free countries) or endorsement of official control programmes.

3.     Diagnosis

Enhance networking between national reference laboratories, national reference laboratories offering regional services and international reference laboratories and in time, increase the number of WOAH/FAO Reference Laboratories in Africa.
  • Strengthening, expansion and consolidation of the ERFAN-led network of CBPP laboratories (currently 12 African countries);
  • Supporting WOAH Twinning Agreements, fostering the capabilities for CBPP (and CCPP) advanced diagnosis;
  • Encouraging one laboratory in West/Central Africa and one laboratory in Eastern Africa to apply for Reference Laboratory status.
  • Supporting local production of CBPP diagnostic kits

4.     Vaccines

Availability of good quality vaccines and vaccination approaches to increase vaccination coverage and efficacy.
  • Promote systematic quality control through AU-PANVAC;
  • Understanding the reasons for low production capacity (planning, supply vs. demand);
  • Support vaccine manufacturers to meet the required CBPP vaccine potency;
  • Review vaccination strategies, in terms of:
  1. Increasing efficiency for vaccine distribution (supply chains and cold chain management up to community level);
  2. Improving vaccine coverage (better targeting and quality data collection);
  3. Better planning and synchronisation of vaccinations with stakeholders and farming communities (linked with strain used, antibiotic stewardship and desired protection levels);
  4. Understanding the causes of adverse reactions in vaccination;
  5. Post-vaccination monitoring approaches;
  6. Opportunities to synchronise vaccinations with other vaccinations, in the same or other species or in other field activities.

5.     Policy

Policy issues pertaining to the continuum between private good, public good and the development of PPPs, for improved supply and demand of inputs,  enhanced (movement) control, cross-border cooperation and export-trade facilitation.
  • Promoting the transparent reporting of cases (and fight reporting aversion);
  • Understanding the reasons for low production capacity (planning, supply vs demand)
  • Promoting increased CBPP vaccination through community-centered policies, focusing on increasing access to vaccines;
  • Regulation and monitoring of antibiotics use as access to vaccines increases;
  • Apply simple herd-based livestock identification and traceability systems;
  • Promote zoning and compartmentalisation;
  • Private sector incentives and opportunities for PPPs in the areas of vaccines and diagnostics;
  • Promoting collaboration such as MoUs to support cross-border coordination.

6.     Research

Collaboration with research institutions and researchers to generate evidence on:
  • Understanding the socio-economic burden of CBPP;
  • Understanding the drivers in farmers’ risk-avoidance behaviour and decision-making with regards to antibiotics;
  • The effect of antibiotics on sequestrae;
  • The effect of antibiotics on live attenuated vaccines (LAV);
  • The most effective and prudent protocols to combine antibiotic treatment and vaccination;
  • Vaccine candidates (other than the T1 based strains).

 

Regarding the scope, frequency, membership and hosting of upcoming meetings,

it was clarified that :

  1. The SGE format offers the possibility for the sharing or pooling of technical expertise, but is not a funding mechanism;
  2. Every upcoming meeting will only deal with one of the 6 above-mentioned topics;
  3. Subject to availability of funds, face to face meetings will be privileged;
  4. Founding Member Countries will be invited to host on a rotational basis (and chair the meeting). The representative of the COMESA Secretariat will enquire whether it is feasible to host the first face-to-face session of the SGE in 2023 or 2024 in Lusaka, Zambia;
  5. That the next Regional Steering Committee (RSC) endorses the enlargement of the membership to the Animal Health Institute (AHI), the national reference laboratory of Ethiopia, based in Sebeta, as a regional service laboratory;
  6. That the next RSC endorses the enlargement of the membership to one Member country in the North Africa (Maghreb) region to underscore the importance of surveillance and diagnostic capacity to avoid the further spread of the disease from sub-Saharan Africa, including Mauritania;
  7. The frequency of SGE ASF meetings hasn’t been detailed, but 6 topics to be addressed in the next 18 months at most, represents a frequency of 3 months between sessions.

Furthermore, a dedicated SGE page has been opened of the GF-TADs for Africa website in order to facilitate the sharing of information amongst members of the SGE (click the link) : Contagious Bovine Pleuropneumonia – Standing Group of Experts (SGE) – Africa

GF-TADs for Africa

This was an activity of the FAO - WOAH Global Framework for the progressive control of Transboundary Animal Diseases, in cooperation with the African Union

Acknowledgements

Funding for this event was provided by Italy (III)

Read more

GF-TADs for Africa

CBPP Portal

Read more
SGE CBPP

Standing Group of Experts CBPP

Read more
Share this post